CVSGF (CVS Group) ROCE %: 7.37% (As of Dec. 2025)


CVSGF CVS Group PLC CVSGF
90 GF Score
Price $16.55
GF Value $18.82
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is CVS Group ROCE %?

CVS Group CVSGF 90 ROCE % is 7.37% as of Dec. 2025. GuruFocus rates CVSGF with a GF Score™ of 90/100 and a GF Value™ of $18.82 (Modestly Undervalued). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. CVS Group's annualized ROCE % for the quarter that ended in Dec. 2025 was 7.37%.

CVS Group  (OTCPK:CVSGF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

CVS Group ROCE % Related Terms

CVS Group ROCE % Historical Data

* Premium members only.

The historical data trend for CVS Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CVS Group ROCE % Chart

CVS Group Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.19 9.90 15.43 9.06 8.82

CVS Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.23 5.59 8.48 8.76 7.37
CVSGF
90GF Score
CVS Group PLC CVSGF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CVS Group ROCE % Calculation

CVS Group's annualized ROCE % for the fiscal year that ended in Jun. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=66.35/( ( (877.863 - 150.254) + (944.64 - 167.3) )/ 2 )
=66.35/( (727.609+777.34)/ 2 )
=66.35/752.4745
=8.82 %

CVS Group's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=58.1/( ( (944.64 - 167.3) + (959.705 - 160.509) )/ 2 )
=58.1/( ( 777.34 + 799.196 )/ 2 )
=58.1/788.268
=7.37 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 7.37% mean?
CVS Group (CVSGF) has a ROCE % of 7.37% as of Dec. 2025.
Is CVS Group's ROCE % too high?
CVS Group's current ROCE % is 7.37%. The Healthcare Providers & Services industry median ROCE % is 6.43. CVS Group's value of 7.37% is 14.6% above this industry median. Overall, CVS Group has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CVS Group's ROCE % compare to HCA and THC?
CVS Group's ROCE % of 7.37% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.43. CVS Group's value of 7.37% is 14.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.43, based on 645 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CVS Group's current ROCE % of 7.37% is 14.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CVS Group's current ROCE % is 7.37%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CVS Group stock overvalued right now?
Based on GuruFocus' analysis, CVS Group (CVSGF) is currently considered Modestly Undervalued. The stock's GF Value™ is $18.82, compared to a current price of $16.55 — trading 12.1% below its estimated fair value. The current ROCE % is 7.37% and 14.6% above the Healthcare Providers & Services industry median of 6.43. CVS Group's overall GF Score™ is 90/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For CVS Group (CVSGF), the current ROCE % is 7.37% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CVS Group (CVSGF) Overvalued in 2026?

Based on GuruFocus' analysis, CVS Group stock appears to be undervalued. The current stock price of $16.55 is trading 12.1% below its estimated GF Value™ of $18.82. GuruFocus considers CVS Group to be Modestly Undervalued.

Key valuation signals for CVSGF:

  • ROCE %: 7.37%
  • GF Value™: $18.82 vs. price of $16.55 (12.1% below fair value)
  • GF Score™: 90/100 with 4 warning signs
  • Industry Position: 14.6% above the Healthcare Providers & Services median

No single metric tells the full story. See the CVSGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CVS Group Business Description

Other Exchanges CVSGl:UKCVSG:UK4C9:Germany
Address Owen Road, CVS House, Diss, Norfolk, GBR, IP22 4ER
CVS Group PLC is a veterinary service provider in the United Kingdom. The group operates through three business divisions: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. The veterinary practice segment generates the majority of the revenues. The company facilitates its veterinary services through its diagnostics, laboratory reports, and pet cremation services. It also offers retail pharmacy through Animed Direct. Geographically, it generates the majority of its revenue from the United Kingdom and also operates in Australia.
90GF Score

Get the complete analysis for CVSGF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.55
Price
$18.82
GF Value